|Issued By||: Achiko AG|
|Exchange||: SIX Swiss Exchange|
|ISIN number:||: CH0522213468|
|Valor number||: 52’221’346|
|Shares Issued||: 118’985’566|
|Trading currency||: CHF|
5 January 2022 ProActive Investors
Achiko-CEO sagt, der in Indonesien eingeführte COVID-19-Schnelltest sei “dramatisch genauer” als andere (Englisch)
Achiko AG CEO Steven Goh tells Proactive the group has recently completed validated testing of its coronavirus rapid test AptameX in Indonesia, the data to be used to support its CE mark application for the test approval in Europe.
29 November 2021 – Banking in Switzerland and Luxembourg (BSL)
Wie man ein ehrgeiziges Fintech-Unternehmen in ein aufregendes Healthtech-Unternehmen verwandelt (Englisch)
COVID-19 affected Achiko, just like everyone else, and we are grateful to still be here. The company started as a payments aggregator. In early 2020, we were finalising the development of our app and we were also in the process of expanding into a buy now, pay later service.